Otsuka Wins Appeal Ruling Upholding Abilify Drug Patent - Businessweek

Otsuka Holdings Co. (4578)’s pharmaceutical unit and partner Bristol-Myers Squibb Co. (BMY) (BMY) won an appeals court ruling that will help ward off generic-drug competition to their schizophrenia drug Abilify until April 2015. The U.S. Court ...

Abilify Does Well in Depot Version - MedPage Today

Reviewed by Dori F. Zaleznik, MD; Associate Clinical Professor of Medicine, Harvard Medical School, Boston and Dorothy Caputo, MA, BSN, RN, Nurse Planner PHILADELPHIA -- A depot formulation of aripiprazole (Abilify) is on track to join the ranks ...

Newly diagnosed schizophrenia patients continue to use oral Abilify as first-line therapy - News-Medical.Net

BioTrends Research Group, one of the world's leading research and advisory firms for specialized biopharmaceutical issues, finds that analysis of U.S. longitudinal patient-level claims data reveals the use of Bristol-Myers Squibb's oral Abilify ...

Use of Bristol-Myers Squibb’s Oral Abilify is Shifting to First-Line Treatment of Newly Diagnosed Schizophrenia Patients - PharmiWeb

BioTrends Research Group, one of the world’s leading research and advisory firms for specialized biopharmaceutical issues, finds that analysis of U.S. longitudinal patient-level claims data reveals the use of Bristol-Myers Squibb’s oral Abilify as a ...

US court upholds patent on Otsuka, Bristol-Myers Squibb's Abilify - PharmiWeb

Otsuka Pharmaceutical Co., Ltd. and Otsuka Holdings, Co., Ltd., the parent company of Otsuka Pharmaceutical Co., Ltd., announced today that the U.S. Court of Appeals for the Federal Circuit issued its judgment dated May 7, 2012 in favor of Otsuka ...

Fed. Circ. Sides With Otsuka In Abilify Patent Validity Debate - site.law360.com

Law360, New York (May 07, 2012, 5:59 PM ET) -- The Federal Circuit on Monday affirmed a lower court's ruling that the patent for Otsuka Pharmaceutical Co. Ltd.'s schizophrenia drug Abilify was valid and not obvious, rejecting challenges by companies ...

Experimental Drug Improves Autism-Like Symptoms in Mice - ABC News

The two approved drugs — Risperdal and Abilify — are anti-psychotics and can have dangerous side effects, she added. The mice used in the study are commercially bred to exhibit symptoms that strongly resemble those often seen in autism. 

Otsuka Slaps Amneal With IP Suit Over Generic Abilify - site.law360.com

Law360, New York (April 27, 2012, 8:13 PM ET) -- Japanese drugmaker Otsuka Pharmaceuticals Co. Ltd. on Thursday launched a patent infringement suit against Amneal Pharmaceuticals LLC, challenging the rival's attempt to score U.S. approval of a generic ...

Inaugural Harris Poll Physician Pulse(SM) Study: Viagra® and Cialis® are Highest Ranked in Trust - Yahoo Finance

The top-ranked brands that are at or above the average in each category, with a maximum score of 100 are: Lexapro® (74) for ADP, followed by Cymbalta® (72), then Wellbutrin XL® (71); Abilify® (74) for APS, with Seroquel® (73) nipping at its ...

Search Continues for Missing Sun City Woman - WSAV-TV

"My wife theorizes that she was intent on killing herself because she had two recent prescriptions of Abilify and Ceraquil on her along with her purse. No clothes no anything, things that her mother would notice, not even her toothbrush ...